Chapter 27
Myocardial Regenerative Potential by Stem Cell Transplant
Yinhong Chen,
Catherine A. Priest,
Joseph D. Gold,
Yinhong Chen
Search for more papers by this authorCatherine A. Priest
Search for more papers by this authorJoseph D. Gold
Search for more papers by this authorYinhong Chen,
Catherine A. Priest,
Joseph D. Gold,
Yinhong Chen
Search for more papers by this authorCatherine A. Priest
Search for more papers by this authorJoseph D. Gold
Search for more papers by this authorBook Editor(s):Ronald Ross Watson,
Douglas F. Larson,
Ronald Ross Watson
Department of Nutritional Sciences, The University of Arizona; and Sarver Heart Center, College of Medicine, The University of Arizona
Division of Health Promotion Sciences, Mel and Enid Zuckerman Arizona College of Public Health, The University of Arizona Tucson, AZ USA
Search for more papers by this authorDouglas F. Larson
Sarver Heart Center College of Medicine The University of Arizona Tucson, AZ USA
Search for more papers by this authorFirst published: 30 August 2007
Summary
This chapter contains section titled:
-
Introduction
-
Cell types for myocardial regeneration
-
Cord blood-derived cells
-
Embryonic stem cell-derived cardiomyocytes
-
Challenges for clinical application
-
Immunogenicity of stem cells
-
Conclusion
-
References
References
- Laflamme MA Murry C.E. Regenerating the Heart. Nat Biotechnol 2005; 23 (7): 845–56.
- Menasche P Hagege A Scorsin M et al. Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case. Arch Mal Coeur Vaiss 2001; 94 (3): 180–2.
- Reinecke H Poppa V Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002; 34 (2): 241–9.
- Menasche P. Myoblast transfer in Heart failure. Surg Clin North Am 2004; 84 (1): 125–39.
- Dimmeler S Zeiher AM Schneider M.D. Unchain my Heart: the scientific foundations of cardiac repair. J Clin Invest 2005; 115 (3): 572–83.
- Lapidos KA Chen YE Earley J. et al. Transplanted hematopoietic stem cells demonstrate impaired sarcogly-can expression after engraftment into cardiac and skeletal muscle. J Clin Invest 2004; 114 (11): 1577–85.
- Mangi AA Noiseux N Kong D et al. Mesenchy-mal stem cells modified with Akt prevent remodeling and restore performance of infarcted Hearts. Nat Med 2003; 9 (9): 1195–201.
- Ma N Ladilov Y Kaminski A et al. Umbilical cord blood cell transplantation for myocardial regeneration. Transplant Proc 2006; 38: 771–3.
- Henning RJ, Abu-Ali H, Balis JU, Morgan MB, Willing AE, Sanberg P.R. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant 2004; 13: 729–39.
- Beltrami AP Barlucchi L Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114 (6): 763–76.
- Oh H Bradfute SB Gallardo T. et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003; 100 (21): 123 13–8.
- Martin CM, Meeson AP, Robertson SM et al. Persistentex-pression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult Heart. Dev Biol 2004; 265 (1): 262–75.
- Cai CL Liang X Shi Y et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the Heart. Dev Cell 2003; 5 (6): 877–89.
- Laugwitz KL Moretti A Lam J et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005; 433 (7026): 647–53.
- Roell W Lu ZJ Bloch W et al. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 2002; 105 (20): 2435–41.
- Muller-Ehmsen J Peterson KL Kedes L et al. Rebuilding a damaged Heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 2002; 105 (14): 1720–6.
- Itskovitz-Eldor J Schuldiner M Karsenti D et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 2000; 6 (2): 88–95.
- Amit M Carpenter MK Inokuma M. et al. Clonally derived human embryonic stem cell lines maintain pluripo-tency and proliferative potential for prolonged periods of culture. Dev Biol 2000; 227 (2): 271–8.
- Kehat I Kenyagin-Karsenti D Snir M et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108 (3): 407–14.
- Doetschman TC Eistetter H Katz M Schmidt W Kem-ler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 1985; 87: 27–45.
- Klug MG Soonpaa MH Koh GY Field L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 1996; 98 (1): 216–24.
- Muller M Fleischmann BK Selbert S et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 2000; 14 (15): 2540–8.
- Maltsev VA Wobus AM Rohwedel J Bader M Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 1994; 75 (2): 233–44.
- Fijnvandraat AC van Ginneken AC de Boer P. et al. Car-diomyocytes derived from embryonic stem cells resemble cardiomyocytes of the embryonic Heart tube. Cardiovasc Res 2003; 58 (2): 399–409.
- Dinsmore J Ratliff J Deacon T et al. Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation. Cell Transplant 1996; 5 (2): 131–43.
- Min JY Yang Y Converso K. et al. Transplantationof embryonic stem cells improves cardiac function in postin-farcted rats. J Appl Physiol 2002; 92 (1): 288–96.
- Hodgson DM Behfar A Zingman L. et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 2004; 287 (2): H471–9.
- Swijnenburg RJ Tanaka M Vogel, H et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005; 112 (9 suppl): I166–72.
- Menard C Hagege AA Agbulut O et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 2005; 366 (9490): 1005–12.
- Thomson JA Itskovitz-Eldor J Shapiro S. et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282 (5391): 1145–7.
- Xu C Inokuma MS Denham J et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001; 19 (10): 971–4.
- Xu C Police S Rao N Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002; 91 (6): 501–8.
- Laflamme MA Gold J Xu C et al. Formation of human myocardiumin the rat Heart from humanembryonicstem cells. Am J Pathol 2005; 167 (3): 663–71.
- Snir M Kehat I Gepstein A et al. Assessment of the ul-trastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 2003; 285 (6): H2355–63.
- Xu C Rosler E Jiang J et al. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells 2005; 23 (3): 315–23.
- Gold J Hassanipour M Police S et al. Directed differentiation of cardiomyocytes from human embryonic stem cells: characterization and transplantation. In Abstract, 4 th ISSCR Annual Meeting, Toronto, Canada, 2006: 59.
- Xu C Police S Hassanipour M et al. Human embryonic stem cells maintained in non-conditioned medium have capacity to differentiate into cardiomyocytes: progress towards the clinic. In: Abstract, 4th ISSCR Annual Meeting, Toronto, Canada, 2006: 236.
- Kehat I Khimovich L Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22 (10): 1282–9.
- Laflamme MA Gold J Xu C et al. Combinatorial anti-death cocktail improves survival of engrafted human embryonic stem cell derived cardiomyocytes within infarcted Hearts. In: Abstract, Molecular Mechanisms of Cardiac Disease and Regeneration, Keystone Symposium, Sante Fe, NM, 2006: 59.
- Watanabe E Smith DM Jr, Delcarpio J. et al. Cardiomy-ocyte transplantation in a porcine myocardial infarction model. Cell Transplant 1998; 7 (3): 239–46.
- Scorsin M Hagege AA Dolizy I et al. Can cellular transplantation improve function in doxorubicin-induced Heart failure. Circulation 1998; 98 (19 suppl): II151–5; discussion II155–6.
- Toma C Pittenger MF Cahill KS Byrne BJ Kessler P.D. Human mesenchymal stem cells differentiate to a car-diomyocyte phenotype in the adult murine Heart. Circulation 2002; 105 (1): 93–8.
- Taylor DA Atkins BZ Hungspreugs P et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998; 4 (8): 929–33.
- Zhang M Methot D Poppa V Fujio Y Walsh K Murry C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001; 33 (5): 907–21.
- Muller-Ehmsen J Whittaker P Kloner R. et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 2002; 34 (2): 107–16.
- Reinecke H Zhang M Bartosek T Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat Hearts. Circulation 1999; 100: 193–202.
- Tang YL Tang Y Zhang YC Qian K Shen L Phillips M.I. Improved graft mesenchymal stem cell survival in ischemic Heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 2005; 46 (7): 1339–50.
- Yau TM Kim C Li G Zhang Y Weisel RD Li R.K. Maximizing ventricular function with multimodal cell-based gene therapy. Circulation 2005; 112 (9 suppl): I123–8.
- Draper JS Pigott C Thomson JA Andrews P.W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 2002; 200: 249–58.
- Drukker M Katz G Urbach A et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 2002; 99 (15): 9864–9.
- Fandrich F Lin X Chai G. et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementaryhost conditioning. Nat Med 2002; 8 (2): 171–8.
- Kofidis, T, de Bruin JL Tanaka M et al. Theyare notstealthy in the Heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. Eur J Cardiothorac Surg 2005; 28 (3): 461–6.
- Fairchild PJ Cartland S Nolan KF Waldmann H. Embryonic stem cells and the challenge of transplantation tolerance. Trends Immunol 2004; 25 (9): 465–70.
- Wakayama T. On the road to therapeutic cloning. Nat Biotechnol 2004; 22 (4): 399–400.
